Mandate

Vinge is advising on the establishment of Ballista Capital

July 07, 2025

Ballista Capital held its final closing on 9 June 2025. The investor base primarily comprises family offices and investors with strong ties to northern Sweden.

Ballista Capital believes in the potential to generate returns by investing in Swedish small and medium-sized companies that are often overlooked by larger capital flows, with a particular focus on businesses located outside the major metropolitan areas.

Vinge's team primarily consisted of Mattias Schömer, Marcus Andersson, Semir Omerbasic, Erik Kochbati and Emelie Zingmark

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025